Researcher interests: Tumor microenvironment and angiogenesis. Tissue response and resistance to anti-angiogenic therapy. Developing nanotechnology-based anti-angiogenic and anti-cancer with reduced tumor resistance and prolonged efficacy and tumor targeting. Anti-metastatic drugs. Ocular drug delivery systems for treating neovascular eye disease.
FACULTY / SCHOOL: School of Medicine - IMRIC
DEPARTMENT: School of Pharmacy- Institute for Drug Research
Selected Publications
microfluidic based fabrication and characterization of highly porous polymeric microspheres (2019)|
Polymers|
Read more
tissue necrosis and its role in cancer progression (2019)|
Oncogene|
Read more
body on chip a distant dream or an emergingreality (2018)|
Drug Designing & Intellectual Properties International Journal|
Read more
controlled and tunable polymer particles production using a single microfluidic device (2018)|
Applied Nanoscience|
Read more
evolving multidimensional pharmacological approaches to cnv therapy in amd (2018)|
Current Eye Research|
Read more
matrix metalloproteinase 12 promotes tumor propagation in the lung (2018)|
The Journal of Thoracic and Cardiovascular Surgery|
Read more
nerve growth factor induced angiogenesis 1 endothelial cell tube formation assay (2018)|
|
Read more
tumor cells and their crosstalk with endothelial cells in 3d spheroids (2017)|
Scientific Reports|
Read more
vegf preconditioning leads to stem cell remodeling and attenuates age related decay of adult hippocampal neurogenesis (2016)|
Proceedings of the National Academy of Sciences of the United States of America|
Read more
rigidity of polymer micelles affects interactions with tumor cells ()|
Journal of Controlled Release|
Read more
high mobility group box 1 antagonist limits metastatic seeding in the lungs via reduction of cell cell adhesion ()|
Oncotarget|
Read more
